Greater Manchester Mayor Andy Burnham has helped open a collaborative space on a visit to officially mark a partnership ...
Researchers have found a new way to use biocatalysis to improve the production of critical raw materials required for ...
Visit from Manchester Mayor signals a new era of collaboration between two UK innovation hubs with a focus on boosting regional economies and fostering inclusive growth.
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...
Drugmaker AstraZeneca has teamed up with Indian digital ... more than 250,000 images generated at clinics in the Greater Manchester Cancer Alliance, to see if Qure.ai's qXR software can make ...
Over the past three years, additional insurance fraud cases have emerged involving AstraZeneca employees in various Chinese regions. The investigation focuses on potential breaches of data privacy ...
The visit included tours of the Cambridge West Innovation District, Cambridge Graphene Centre, and AstraZeneca’s Discovery Centre (DISC); the pharmaceuticals giant will, through the new partnership, ...
Nov 5 (Reuters) - AstraZeneca (AZN.L), opens new tab shares on Tuesday recorded their worst day since March 2020 after a report that dozens of the drugmaker's senior executives in China could be ...
AstraZeneca may be emphasizing the potential for combination treatments to help its obesity pipeline stand out from the crowd, but the Big Pharma insists it is still “playing to win” in the space.
Researchers have found a new way to use biocatalysis to improve the production of critical raw materials required for essential drugs, making the process quicker, more efficient, and environmentally ...
AstraZeneca is a company with a turbulent history but, for now, a promising future. We take a look at the company's story, from its creation as a merger of two equals, to its recent major ...
As AstraZeneca’s chronic obstructive pulmonary disease drug Breztri continues climbing toward blockbuster status, the Big Pharma is broadening its efforts to support people with COPD.